Maravai LifeSciences Holdings, Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
Maravai LifeSciences Holdings, Inc. (MRVI) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$224.24 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-02-26
- Maravai LifeSciences Holdings, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$224.24M.
- Maravai LifeSciences Holdings, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$261.58M, a 142.35% decline from fiscal 2023.
- Maravai LifeSciences Holdings, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was $617.68M, a 12.01% increase from fiscal 2022.
- Maravai LifeSciences Holdings, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was $551.47M, a 3.88% increase from fiscal 2021.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | -$224.24M 10-K · filed 2026-02-26 |
| 2024-12-31 | -$261.58M 10-K · filed 2026-02-26 |
| 2023-12-31 | $617.68M 10-K · filed 2026-02-26 |
| 2022-12-31 | $551.47M 10-K · filed 2025-03-18 |
| 2021-12-31 | $530.85M 10-K · filed 2024-02-29 |
| 2020-12-31 | $82.01M 10-K · filed 2023-02-28 |
| 2019-12-31 | -$5.58M 10-K · filed 2022-03-01 |